Revolution Medicines, Inc.
MX ˙ BMV ˙ US76155X1000
SecurityMX:RVMD / Revolution Medicines, Inc.
InstitutionStemPoint Capital LP
Latest Disclosed Ownership281,632 shares
Latest Disclosed Value $ 27,388,712
StemPoint Capital LP ownership in RVMD / Revolution Medicines, Inc.

On May 18, 2026 - StemPoint Capital LP filed a 13F-HR/A form disclosing ownership of 281,632 shares of Revolution Medicines, Inc. (MX:RVMD) valued at $27,388,712 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 62,032 shares of Revolution Medicines, Inc.. This represents a change in shares of 354.01% during the quarter.

StemPoint Capital LP has a history of taking positions in derivatives of the underlying security (RVMD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:RVMD / Revolution Medicines, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 281,632 219,600 354.01 27,389 454.41 5.2434
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 281,632 219,600 27,389 5.3190
2026-02-17 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 62,032 -123,348 -66.54 4,941 -42.94 0.8472
2025-11-14 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 185,380 185,380 8,657 1.7346
2025-08-14 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 0 -318,782 -100.00 0 -100.00
2025-05-15 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 318,782 125,247 64.72 11,272 33.16 3.5933
2025-02-14 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 193,535 176,881 1,062.09 8,465 1,021.19 2.1132
2024-11-13 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 16,654 16,654 755 0.2261
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-18 2026-03-31 13F/A REVOLUTION MEDICINES COM Put 100,000 525 n/a n/a n/a
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES COM Put 100,000 525 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.